Frontage Laboratories, Inc.
Frontage is a global CRO focused on early stage drug development, delivering services including bioanalysis, DMPK, Phase I-IIA clinical studies, and CMC product development. Our team of dedicated scientists and skilled business professionals across multiple business units gives us the ability to maneuver the drug development process in a timely and cost-effective manner. We work with small and large molecules for novel biopharmaceuticals as well as generic-equivalent and consumer products.